Evogene Ltd (NASDAQ: EVGN)
$1.4600
+0.1100 ( +5.80% ) 73.9K
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
Market Data
Open
$1.4600
Previous close
$1.3500
Volume
73.9K
Market cap
$9.54M
Day range
$1.3500 - $1.4750
52 week range
$1.2000 - $10.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 1 | Nov 27, 2024 |
6-k | Form 6-K | 29 | Nov 21, 2024 |
6-k | Form 6-K | 1 | Sep 17, 2024 |
6-k | Form 6-K | 55 | Sep 16, 2024 |
6-k | Form 6-K | 14 | Aug 23, 2024 |
6-k | Form 6-K | 35 | Aug 22, 2024 |
6-k | Form 6-K | 3 | Aug 12, 2024 |
6-k | Form 6-K | 3 | Jul 23, 2024 |
6-k | Form 6-K | 4 | Jun 25, 2024 |
6-k | Form 6-K | 1 | Jun 20, 2024 |